As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, it offers a novel approach to treatment: Mechanism of action Tirzepatide effectively stimulates insulin release from the pancreas, which helps to reduce hyperglycemia
The platform provides the technology infrastructure, customer service, and coordination that enables the telehealth experience
With retatrutide, the curve continues descending through this entire period, driven in part by the ongoing glucagon receptor activation that other medications lack
Some patients respond better to one medication than the other depending on tolerance and metabolic response
Not all telehealth platforms provide this flexibility
Learning to recognize early signs of low blood sugar, including shakiness, sweating, confusion, and rapid heartbeat, allows you to respond quickly